Express Diagnostics Partners with Project GHB to Increase Awareness of Effects of GHB
New DrugCheck® onsite GHB Single Test central to partnership’s goals.
Blue Earth, Minn. (PRWEB) April 24, 2013
Express Diagnostics Int’l Inc. (EDI), manufacturer of DrugCheck® onsite testing devices, today announced a partnership with Project GHB to increase awareness of the dangerous effects of the drug GHB (gamma hydroxybutyrate). Under the partnership, and as part of the organization’s educational outreach, Project GHB will include information on the new DrugCheck GHB Single Test, which detects the drug in urine samples. Express Diagnostics will provide support material and donate a portion of GHB Single Test sales to Project GHB back to the 501(c)(3) non-profit organization. The donated funds will help further the group’s mission of increasing awareness of the dangerous effects of GHB.
